Meloxicam Tablet
FDA Label NDC 65841-050

2 label sections · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Meloxicam (NDC 65841-050). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding spl medguide, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Spl Medguide

Manufactured by:

Cadila Healthcare Ltd.

India.

Package Label.Principal Display Panel

NDC 65841-050-01 in bottle of 500 tablets

Meloxicam Tablets USP, 7.5 mg

Rx only

500 tablets

Meloxicam Tablets, 7.5 mg (E2e7eb0f 7da0 45cd 93d8 D49ea6756d73 01)

Meloxicam Tablets, 7.5 mg (E2e7eb0f 7da0 45cd 93d8 D49ea6756d73 01)

NDC 65841-051-01 in bottle of 500 tablets

Meloxicam Tablets USP, 15 mg

Rx only

500 tablets

Meloxicam Tablets, 15 mg (E2e7eb0f 7da0 45cd 93d8 D49ea6756d73 02)

Meloxicam Tablets, 15 mg (E2e7eb0f 7da0 45cd 93d8 D49ea6756d73 02)

* Please review the disclaimer below.